ArticlePharmacy (Basel, Switzerland)2023

Exploring Concomitant Acetylcholinesterase Inhibitor and Overactive Bladder Anticholinergic Use and Risk of Hospitalization in Medicare and Dual-Eligible Medicare-Medicaid Populations in a Historic Database.

Jonathan H Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.